Cytiva expands portfolio with new MabSelect Resins made from renewable agarose for scalable, cost-efficient mAb manufacturing Read more
Trump tariffs on the pharmaceutical sector. A new twist- the US department of commerce initiates a Section 232 investigation Read more
Global divide emerges among physicians over patient choice in biologics vs. biosimilars, reveals GlobalData Read more
PADCEV™ (enfortumab vedotin) now available in India for locally advanced or metastatic urothelial cancer Read more
Syngene collaborates with biotech firm to develop bile acid modulator for cholestatic disease treatment Read more
Innovent’s Sycume to transform thyroid eye disease treatment landscape in China and Asia: GlobalData Read more